Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
31 results
- D3.164 - Safety and Efficacy of VIT against Wasp Venom in Patients Older than 60 Years
- D3.165 - Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis
- D3.166 - The mental health of adolescent patients with cat allergy improves with rapid dosing of depigmented cat allergoids
- D3.167 - Allergoids: Characterising Identity Pre- and Post- Modification Using Compendial and Novel Methods
- D3.169 - Advantage of IgG reactivity testing for the analytical quantification of allergoids
- D3.172 - Аllergen-specific immunotherapy in patients with allergic rhinitis
- D3.173 - Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)
- D3.174 - Comparative analysis of extracts from Cupressus arizonica and Juniperus ashei pollens
- D3.175 - Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model
- D3.176 - The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma
- D3.177 - Potency of Dermatophagoides spp SLIT tablet compared to US standardized mite in ID testing
D3.170 - Effectiveness and Safety Study of Subcutaneous Immunotherapy for Respiratory Allergy to Dermatophagoides and Lepidoglyphus Destructor
D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention
D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)
D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)
D3.392 - What information and education is crucial for people with food allergies?
D3.393 - Daily life with a peanut allergy, as a young adult- an interview study
D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy
D3.395 - Evaluation for suspected penicillin allergy - the patient perspective
D3.398 - Food provision experience of inpatients with adverse food reactions in the acute hospital setting
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download